DCBO— AI Stock Forecast & Price Targets

Published 7/30/2026 · A free sample of K3vl4r’s AI-powered analysis.

Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.

View the live DCBO price forecast →

Docebo's recent stock repurchase and Q2 results provide near-term catalysts, but elevated short interest and weak momentum suggest caution despite positive fundamentals. The technical analysis shows current trading around $20.81, with support at $14.39 (52-week low).

ACCUMULATE
medium convictiongenerated 7/30/2026, 11:56:26 PM
Scores
Fundamentals
7.0
Technicals
5.5
Growth potential
7.0
Risk
6.0
Overall
6.0
Charts the model saw
Bear
$17.50
Base
$23.42
Bull
$29.75
over ~6 months
Investment plan
Short term · 1-4 weeks

Hold near current levels ($20.81). Invalidation is below $19.00, which would trigger a short-term sell.

Mid term · 1-6 months

Accumulate if earnings beat expectations (Aug 7), targeting $28.50 based on Needham's price target. Catalysts include Q3 sales guidance ($69.5M-$69.7M) and potential further share repurchases. Change of mind if short float rises above 10% or if EPS misses by more than 5%.

Long term · 1-3 years

Long-term thesis is based on Docebo's AI-powered platform growth, with terminal value driven by market share gains in the LMS space.

Fundamentals

Revenue grew 12.5%-12.9% YoY to $68.3M-$68.5M in Q2. Gross margins were at 79.67%. The company has strong cash flow ($43.06M FCF) and a current ratio of 0.851. The $70M share repurchase provides capital allocation discipline, and the forward P/E of 10.38 suggests valuation remains relatively attractive.

Technicals

The chart shows a downtrend with recent price action near the 52-week low ($14.39) and current trading around $20.81. Support is at $14.39 (52-week low), while resistance is at $20.81 (current price). The Kronos AI forecast shows a narrow band with actual price near the lower end of the range ($20.81 vs forecast $21.844), indicating potential for a short-term bounce but limited upside. RSI at 59.47 suggests neutral momentum, and the 5-day decline (-5.5%) indicates recent weakness.

News read

The most significant news is Docebo's announcement of a $70M share repurchase at $20.40 per share and preliminary Q2 results showing sales growth of 12.5%-12.9% YoY. Needham reiterated Buy with a $31 price target. The recent 5-day decline (-5.5%) indicates potential downside risk.

Growth / roadmap
  • Q3 sales guidance of $69.5M-$69.7M shows continued revenue expansion
  • $70M stock repurchase demonstrates capital allocation discipline
Risks
  • Earnings miss due to negative operating margins in Q2
  • Short float at 6.52% could amplify downside if sentiment turns bearish
  • Competitive pressure from larger LMS providers

Get AI analysis on any stock

This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.